List of Excipients in API loxapine
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing loxapine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 | ANHYDROUS LACTOSE |
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 | CROSCARMELLOSE SODIUM |
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 | D&C YELLOW NO. 10 |
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 | FD&C BLUE NO. 1 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for loxapine
Excipient focus: ALCOHOL
loxapine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| Chartwell RX LLC | loxapine | 62135-492 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
loxapine drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | loxapine | 50090-4701 |
| Coupler LLC | loxapine | 67046-1478 |
| Coupler LLC | loxapine | 67046-1485 |
| REMEDYREPACK INC | loxapine | 70518-1681 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
loxapine drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| Chartwell RX LLC | loxapine | 62135-492 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
loxapine drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
loxapine drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
loxapine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| Carilion Materials Management | loxapine | 68151-2875 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLPARABEN
loxapine drug variants containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
loxapine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
loxapine drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | loxapine | 50090-4701 |
| Coupler LLC | loxapine | 67046-1485 |
| REMEDYREPACK INC | loxapine | 70518-1681 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
loxapine drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| Chartwell RX LLC | loxapine | 62135-492 |
| Coupler LLC | loxapine | 67046-1479 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
loxapine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| REMEDYREPACK INC | loxapine | 70518-0416 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
loxapine drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE CALCIUM DISODIUM
loxapine drug variants containing EDETATE CALCIUM DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing EDETATE CALCIUM DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
loxapine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
loxapine drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
loxapine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| Coupler LLC | loxapine | 67046-1478 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
loxapine drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
loxapine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Chartwell RX LLC | loxapine | 62135-492 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
loxapine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| Coupler LLC | loxapine | 67046-1478 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
loxapine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
loxapine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Chartwell RX LLC | loxapine | 62135-492 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
loxapine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
loxapine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
loxapine drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| Chartwell RX LLC | loxapine | 62135-492 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
loxapine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
loxapine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
loxapine drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | loxapine | 50090-4701 |
| Coupler LLC | loxapine | 67046-1478 |
| Coupler LLC | loxapine | 67046-1485 |
| REMEDYREPACK INC | loxapine | 70518-1681 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
loxapine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN POTASSIUM
loxapine drug variants containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| A-S Medication Solutions | loxapine | 50090-4701 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| A-S Medication Solutions | loxapine | 50090-3457 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
loxapine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
loxapine drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
loxapine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
loxapine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
loxapine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PROPIONATE
loxapine drug variants containing SODIUM PROPIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | loxapine | 0591-0369 |
| Carilion Materials Management | loxapine | 68151-2875 |
| REMEDYREPACK INC | loxapine | 70518-0283 |
| REMEDYREPACK INC | loxapine | 70518-0346 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing SODIUM PROPIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
loxapine drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | loxapine | 35573-436 |
| Elite Laboratories Inc | loxapine | 64850-890 |
| REMEDYREPACK INC | loxapine | 70518-4311 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
loxapine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | loxapine | 0378-7005 |
| Lannett Company Inc | loxapine | 0527-1394 |
| Actavis Pharma Inc | loxapine | 0591-0369 |
| ATLANTIC BIOLOGICALS CORP | loxapine | 17856-1397 |
| >Company | >Ingredient | >NDC |
loxapine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
